Written by :
Posted on :

January 15, 2022

Kolosis BIO Announces Relocation of its Headquarters to Historic Salt Lake Building

Salt Lake City, Utah, January 15, 2022

Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the relocation of its global headquarters to the historic Seed Building in downtown Salt Lake City.

“We are excited to expand our presence in Salt Lake City and make the historic Seed Building our global headquarters,” said Maxwell Hunter, COO at Kolosis. “Securing this facility will provide the company with important space to expand its operations, an exceptional work environment for our team, and a terrific setting to host sales partners and caregivers from around the country.”

The Seed Building is located a block from the Salt Lake Rio Grande Depot, originally built in 1910, and a hub for commerce and travelers to the Salt Lake Valley throughout the 20th century. The Seed Building was built in 1917 and supported the local farming community by providing access to out-of-state agricultural products needed to support the growing population in the valley.

About Kolosis BIO:

Kolosis BIO is a leading provider of innovative biologic solutions, dedicated to commercializing cutting-edge technologies and delivering market-leading products to the orthopedic industry. As a pure-play biologics company, Kolosis BIO exclusively partners with MTF Biologics to offer superior quality bone graft technologies such as Kore Fiber, a 100% cortical fiber allograft and Prime HD, a pre-hydrated DBM. These allografts are backed by MTF’s proprietary aseptic processing methods that optimally preserve matrix structures and osteoinductive properties.

As the company looks to the future, Kolosis is dedicated to driving innovation in the biologics field, expanding its product offerings and pushing the boundaries of science to enhance patient outcomes. With a focus on relentless execution and bold technologies, Kolosis BIO endeavors to become a leading force in the biologics market. For more information, please visit

About MTF Biologics:

MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. They provide unmatched service, resources, and expertise to donors and their loved ones who give the gift of donation, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists.

The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals and patients that they serve. Its sister organization, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation), expands its reach to patients across the globe. For more information, visit